heart disease

Showing 15 posts of 21 posts found.

Insider Interview: Reducing the risk of adverse cardiovascular events

February 3, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Insider Interview, cardiovascular, heart disease, pharma

Rodrigo Gribble, Vice President Cardiovascular at AstraZeneca, breaks down recently published data from the PEGASUS trial of ticagrelor, a potential …

AstraZeneca to discontinue trial for heart disease drug Epanova

January 13, 2020
Sales and Marketing AstraZeneca, Phase II Trial, Phase III trial, heart disease, triglycerides

AstraZeneca expects a $100 million writedown for its heart disease drug Epanova, as it discontinues its late stage trial. This …


FDA approves alternative approach for Abbot HeartMate 3 heart pump

January 8, 2020
Research and Development Abbott, FDA, Heart Pump, US Pharma, heart disease

The FDA announced today that it has approved a new alternative surgical technique for Abbot’s HeartMate 3 heart pump. The …


AstraZeneca and Novoheart team up to develop human ‘heart-in-a-jar’

November 27, 2019
Research and Development Heart in a Jar, Novoheart, heart disease

AstraZeneca and Novoheart are collaborating on developing a functioning miniature human heart model of heart failure, a first of its …

Heart disease deaths increase for first time in 50 years

May 13, 2019
Sales and Marketing BHF, UK, cardiovascular, health, heart disease, obesity

Deaths from heart disease among people under the age of 75 have increased for the first time in 50 years. …

Galectin-3: The protein paving new treatment avenues

November 1, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Galectin-3, Galectins, breast cancer, diabetes, heart disease, pharma

Matthew Blakeley, LADI-III Beamline Scientist at Institut Laue-Langevin (ILL) and Derek Logan, Associate Professor in Structural Biology at Lund University, …


“Triple pill” blood pressure combo proves more effective, safe than standard care

August 16, 2018
Research and Development blood pressure, heart attack, heart disease, pharma, triple pill

A “triple pill” combining three established and effective drugs at low dosage levels could prove much more effective in treating …


EMA issues global recall of heart drugs over cancer risk contamination

July 10, 2018
Manufacturing and Production EMA, Europe, heart disease, pharma, valsartan

Several drugs designed for the treatment of high blood pressure and heart conditions have been recalled across Europe over fears …


New AI system for lung cancer and heart disease could save NHS billions

January 4, 2018
Research and Development, Sales and Marketing Optellum, Oxford, Sir John Bell, heart disease, lung cancer, pharma

A team of researchers at Oxford’s John Radcliffe Hospital have unveiled a new artificial intelligence system which they claim could …


Novartis targets specific patient population with strong Ilaris Phase 3 data

November 14, 2017
Manufacturing and Production, Research and Development Ilaris, Novartis, cardiovascular, heart attack, heart disease, pharma

Novartis has presented new Phase 3 data on its cardiovascular drug Ilaris (canakinumab) which demonstrate particular efficacy in a specific …


MSD scores trial success in reducing cardiovascular risk

August 29, 2017
Manufacturing and Production, Research and Development MSD, heart attack, heart disease, life sciences, pharma, pharmaceutical

New data on MSD’s anacetrapib has revealed that the drug was able to reduce risk of the risk of major …


Where will the next cardiovascular breakthrough come from?

August 17, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing British Heart Foundation, cardiovascular disease, heart, heart disease, pharma, pharmaceutical

British Heart Foundation’s Jennifer Mitchell, Research Communications Officer, explains the work they are doing to find the next breakthrough treatment …


Mending broken hearts with an injectable patch

August 16, 2017
Research and Development biotech, cardiovascular, drugs, heart disease, pharma, pharmaceutical

A team of researchers from the University of Toronto have confronted a problem that had previously had no solution – …


Heart failure mortality rates fall across England and Wales, national audit finds

August 11, 2017
Medical Communications, Research and Development cardiovascular, heart, heart disease, life sciences, pharma, pharmaceutical

Great news in the cardiovascular space as results from the National Heart Failure Audit indicate that better treatment has led …

Latest content